TH62549A - Use of CYP2D6 inhibitors in combination therapy - Google Patents
Use of CYP2D6 inhibitors in combination therapyInfo
- Publication number
- TH62549A TH62549A TH1001067A TH0001001067A TH62549A TH 62549 A TH62549 A TH 62549A TH 1001067 A TH1001067 A TH 1001067A TH 0001001067 A TH0001001067 A TH 0001001067A TH 62549 A TH62549 A TH 62549A
- Authority
- TH
- Thailand
- Prior art keywords
- cyp2d6
- drugs
- cyp2d6 inhibitors
- combination therapy
- inhibitors
- Prior art date
Links
- 208000007220 Cytochrome P-450 CYP2D6 Inhibitors Diseases 0.000 title claims abstract 7
- 238000002648 combination therapy Methods 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract 10
- 229940079593 drug Drugs 0.000 claims abstract 9
- 108010001237 Cytochrome P-450 CYP2D6 Proteins 0.000 claims abstract 3
- 102100021704 Cytochrome P450 2D6 Human genes 0.000 claims abstract 3
- 230000008030 elimination Effects 0.000 claims 2
- 238000003379 elimination reaction Methods 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 230000004526 pharmaceutical effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000009466 transformation Effects 0.000 claims 1
- 239000002207 metabolite Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
Abstract
DC60 (14/06/43) การประดิษฐ์นี้ เกี่ยวข้องกับการใช้สารยับยั้ง CYP2D6 ร่วมกับยาที่มีเมตาโบลิซึมที่เร่งโดย CYP2D6 ซึ่งยานั้น และสาร ยับยั้ง CYP2D6 ไม่ใช่สารชนิดเดียวกัน, และสารผสมทางเภสัช กรรมสำหรับการ ใช้ดังกล่าว การประดิษฐ์นี้ เกี่ยวข้องกับการใช้สารยับยั้ง CYP2D6 ร่วมกับยาที่มีเมตาโบลิซึมที่เร่งโดย CYP2D6 ซึ่งยานั้น และสาร ยับยั้ง CYP2D6 ไม่ใช่สารชนิดเดียวกัน, และสารผสมทางเภสัช กรรมสำหรับการ ใช้ดังกล่าว สิทธิบัตรยา DC60 (14/06/43) This invention It was associated with the use of a CYP2D6 inhibitor with a drug with metabolites accelerated by CYP2D6, in which the drug and the CYP2D6 inhibitor were not the same, and the pharmacokinetic mixtures. Karma for such use, this invention It was associated with the use of a CYP2D6 inhibitor with a drug with metabolites accelerated by CYP2D6, in which the drug and the CYP2D6 inhibitor were not the same, and the pharmacokinetic mixtures. Karma for the use of such patent medicine
Claims (2)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH62549A true TH62549A (en) | 2004-06-23 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032734D0 (en) | New 1,2-diphenyllazetidinone derivatives, process for their preparation, drugs containing said compounds and use of these for the treatment of diseases from lipid metabolism | |
| DE602004029580D1 (en) | SUBSTITUTED INDOIND DERIVATIVES FOR A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES | |
| SE0104340D0 (en) | New compounds | |
| NO324227B1 (en) | Cyclopropyl-fused pyrrolidine-based compounds, pharmaceutical compositions and combinations containing them as well as the use thereof for the manufacture of medicaments for the treatment of diseases | |
| AR035792A1 (en) | COMPOUNDS OF N- (4-QUINAZOLINIL) -N- (1H-INDAZOL-5-IL) AMINA, INHIBITOR OF RHO-KINASE, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND METHOD TO PREPARE IT | |
| GB0222514D0 (en) | Organic compounds | |
| ATE409185T1 (en) | QUINAZOLINE DERIVATIVES | |
| HUP0300290A2 (en) | Combination therapies with vascular damaging activity | |
| AR035889A1 (en) | CITRATE OF 5,7,14-TRIAZATETRACICLO [10.3.1.02,11.04,9] HEXADECA-2 (11), 3,5,7,9- PENTAENE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND ITS USE FOR THE DEVELOPMENT OF MEDICINES | |
| CY1107231T1 (en) | Substituted 4-Aminocyclohexanol derivatives | |
| TH62549A (en) | Use of CYP2D6 inhibitors in combination therapy | |
| UA90504C2 (en) | Novel drugs for treating respiratory diseases | |
| CY1105545T1 (en) | STATIN THERAPY TO ENHANCE THE PRESERVATION OF MENTAL FUNCTION | |
| BR0112690A (en) | Cilansetron-containing drug for the treatment of non-constipative male ibs patients | |
| WO2003066806A3 (en) | Therapeutic use of aziridino compounds | |
| TH77896A (en) | New compound | |
| TH63498A (en) | Methods and mixtures for treating pain from cancer | |
| BR0312333A (en) | Combination therapy and agent for its execution | |
| ATE301455T1 (en) | PHARMACEUTICAL PREPARATION CONTAINING VALACICLOVIR | |
| TH76783A (en) | New compound | |
| TH95767A (en) | New compound II | |
| TH78122A (en) | New compounds | |
| TH65934A (en) | Drugs which contain betametic And the new anticolinergic | |
| TH49272A (en) | New use | |
| TH81375A (en) | New compound |